Japanese Pacemaker Payment Reclassification Should Be Delayed - HIMA
This article was originally published in The Gray Sheet
Executive Summary
Japan's proposed reclassification of pacemaker reimbursement from a "by-brand" to a "by-function" system on April 1, 2000 should be postponed pending refinements to the country's reimbursement classification methodology, the Health Industry Manufacturers Association feels.
You may also be interested in...
Japan Tempers Anticipated Price Cuts In Cardiology, Orthopedic Categories
Japan's Ministry of Health and Welfare plans to reduce reimbursement levels for heart valves and stents by an average of only 1% and 0.6% respectively, cuts far lower than industry originally had anticipated.
Japan Tempers Anticipated Price Cuts In Cardiology, Orthopedic Categories
Japan's Ministry of Health and Welfare plans to reduce reimbursement levels for heart valves and stents by an average of only 1% and 0.6% respectively, cuts far lower than industry originally had anticipated.
Japan expected to cut device reimbursement "R-zone" in half to 7-8% by April 1999.
JAPAN LIKELY TO CUT MEDICAL DEVICE "R-ZONE" IN HALF BY APRIL 1999 TO 7-8% from the current 15% level, according to staffers at the U.S. Department of Commerce and the Health Industry Manufacturers Association. The R-zone, the amount by which prices can be cut in Japan without a corresponding reduction in reimbursement, is designed to encourage manufacturers to compete on the basis of price.